Abiopharma

ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent

Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Nutriband CEO Publishes Letter to Shareholders

Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

Shareholder Alert: The Ademi Firm investigates whether FONAR Corporation is obtaining a Fair Price for its Public Shareholders

Haw Par Corporation Limited - Announcement